Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 769 shares at $486.35 ($373K) on 2026-02-25, disclosed to the SEC on 2026-02-26.
Scheduled sale ($373k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $485.11 | 546 | $265K | 70.9% |
| 2 | $486.35 | 223 | $108K | 29.1% |
| Total | $485.47 avg | 769 | $373K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |
| VRTX | SELL | 2025-02-19 | $611K | — | Filing → |